Home

JONATHAN T MD LORD

CIK 1112980 · Sr VP & Chief Innovation Off. · last filed 2023-06-12

JONATHAN T MD LORD is a Sr VP & Chief Innovation Off. who has filed 70 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for BIOL, was dated Jun 12, 2023. Across all open-market trades the lifetime net is −$16.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $36.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$36.79M

Companies

4

Total Filings

70

Lifetime Open-Market Net

-$16.84M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BIOLASE, INC (BIOL) Delisted Director 599 $0.02 $10 $391.9K 29 2023-06-12
DXCM Director 211,280 $70.48 $14.89M -$8.55M 18 2016-09-06
STERICYCLE INC (SRCL) Delisted Director 6,140 $61.98 $380.6K -$2.34M 12 2013-07-02
HUM Sr VP & Chief Innovation Off. 55,507 $394.50 $21.90M -$6.33M 9 2009-05-06

Recent Filings

70 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-06-12 BIOLASE, INC (BIOL) Delisted Grant (A) — $0 EDGAR
2022-12-08 BIOLASE, INC (BIOL) Delisted Sell (S) −3,537 -$2.7K EDGAR
2022-05-12 BIOLASE, INC (BIOL) Delisted Grant (A) — $0 EDGAR
2022-05-02 BIOLASE, INC (BIOL) Delisted Disp (D) −1,395 $0 EDGAR
2021-12-16 BIOLASE, INC (BIOL) Delisted Sell (S) −11,038 -$4.2K EDGAR
2021-06-14 BIOLASE, INC (BIOL) Delisted Grant (A) — $0 EDGAR
2020-08-10 BIOLASE, INC (BIOL) Delisted Grant (A) — $0 EDGAR
2020-07-23 BIOLASE, INC (BIOL) Delisted Grant (A) — $0 EDGAR
2020-05-28 BIOLASE, INC (BIOL) Delisted Grant (A) — $0 EDGAR
2019-08-09 BIOLASE, INC (BIOL) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 70
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.